
1.32BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
NL0015285941
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
3.81
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.95
Wall Street Target Price
18.89
EPS Estimate Current Year
-1.94
EPS Estimate Next Year
-1.90
EPS Estimate Current Quarter
-0.4386
EPS Estimate Next Quarter
-0.4619
Most Recent Quarter
-
Revenue TTM
37,296,000
Gross Profit TTM
-163,814,000
EBITDA
-203,930,000
Profit Margin
0.00%
Return On Assets TTM
-22.44%
Return On Equity TTM
-43.21%
Revenue Per Share TTM
0.297
Qtly Revenue Growth YOY
-59.00%
Diluted Eps TTM
-1.95
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
33.8238
Price Book MRQ
2.5488
Enterprise Value Revenue
19
Enterprise Value EBITDA
7
21.58
2.27%185.30
0.69%935.38
0.00%86.38
0.00%271.69
-2.74%282.93
-1.92%859.51
-1.90%132.25
-1.37%657.00
-0.94%476.99
-0.69%